FdaApplication
ANDA 219777
Identifiers
- fda_app_no: ANDA219777
Properties
| Property | Value |
|---|---|
| applicant_name | ASPIRO PHARMA LTD |
| application_type | ANDA |
| approval_date | 2025-05-28 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | 25GM/50ML (500MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | 1GM/2ML (500MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | 10GM/20ML (500MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
| MAGNESIUM SULFATE | MAGNESIUM SULFATE | 5GM/10ML (500MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS |
4 products